The long winter for biotech stocks is over. Shares have climbed to levels not seen since late 2021, buoyed by eye-popping ...

The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.

Nirogacestat therapy shows sustained benefits, including tumor shrinkage and durable responses, in long-term treatment of ...

Gabelli Enterprise Mergers and Acquisitions Fund reports a 32 percent rise in deal volume this year. Learn how global deals ...